Найти книгу: "The Alzheimer's Epidemic"

The &quot;Alzheimer&#39;s Epidemic&quot; has begun. As the number of aged individuals worldwide continues to grow the epidemic will continue unabated. Alzheimer&#39;s disease will affect one in three families. In addition to the devastating implications of this epidemic to Alzheimer&#39;s sufferers, their families and caregivers, the economic costs to society will be enormous. Around the world governments are struggling with ways to deal with this unrelenting tide that will soon be a medical tsunami that will challenge many societies&#39; ability to cope. At the front of this attempt to stem the tide are biomedical researchers worldwide who are working diligently to understand the causes of Alzheimer&#39;s, which will allow them to formulate ways to slow the progression of the disease and someday stop it from occurring. <br><br>In 16 chapters with over 100 original full color figures, this book looks in depth at this &quot;Alzheimer&#39;s Epidemic&quot; by focusing on the causes and the search for a cure. Other books have dealt in detail with the symptoms of the disease and how to care for those suffering with the disease. This book is significantly different from those that have gone before. The content is gleaned from original research and reviews including recent international meetings. The authors&#39; strong science background and research on proteins linked to the disease has allowed him to look at Alzheimer&#39;s disease from a wide base of knowledge which leads to some new insights into the origins and future of the disease. This book sets the stage for an in-depth understanding of what is being done and where research is going in the quest to understand the causes and find a cure for an unrelenting disease that paves the way to dementia for those it affects.

Your sensitive, authoritative guide to Alzheimer's and dementia If a loved one has recently been diagnosed with dementia or Alzheimer's disease, it's only natural to feel fraught with fear and uncertainty about what lies ahead. Fortunately, you don't have to do it alone. This friendly and authoritative guide is here to help you make smart, informed choices throughout the different scenarios you'll encounter as a person caring for someone diagnosed with dementia or Alzheimer's disease. From making sense of a diagnosis to the best ways to cope with symptoms, Alzheimer's and Dementia For Dummies is the trusted companion you can count on as you navigate your way through this difficult landscape. Affecting one's memory, thinking, and behavior, dementia and Alzheimer's disease can't be prevented, cured, or slowed—but a diagnosis doesn't mean you have to be left helpless! Inside, you'll find out how to make sense of the symptoms of dementia and Alzheimer's disease, understand the stages of the illnesses, and, most importantly, keep your loved one safe and comfortable—no matter how severe their symptoms are. Find out what to expect from Alzheimer's and dementia Discover what to keep in mind while caring for someone with Alzheimer's or dementia Uncover symptoms, causes, and risk factors of Alzheimer's and dementia Learn the critical information needed to help manage these illnesses Whether you're new to caring for a person affected by Alzheimer's or dementia or just looking for some answers and relief on your journey, this is the trusted resource you'll turn to again and again.

Bestselling author John Talbott outlines the troublesome economic times ahead and what can be done about them Tough times are here, and author John Talbott-who accurately predicted the dot.com technology stock collapse as well as the recent housing, mortgage, and financial crises-argues that the coming global recession will be unlike anything we've ever seen. In Contagion, Talbott turns his attention to this crisis and offers insights on what can be done to navigate such treacherous terrain. Talbott sets the stage by discussing how government borrowing and spending on the war, healthcare, Social Security, and corporate giveaways combined with dramatic increases in personal spending, fueled by credit card and mortgage debt, have funded unsustainable levels of personal and government consumption. Offers practical suggestions as to how investors and homeowners can best weather this storm with straightforward advice on where to invest Examines real estate and housing issues to help you make the best decisions possible in this arena Details the best ways to utilize stocks, bonds, TIPS, and commodities, and to prosper during this global crisis If you really want to protect yourself from the unfolding economic crisis, then Contagion is the book you need to read.

The crime of the twenty-first century doesn't discriminate: ID theft has hit ordinary citizens and celebrities alike, from Oprah Winfrey to Steven Spielberg, and costs the economy $50 billion a year. Your Evil Twin covers this exploding crime from every possible angle. It includes exclusive whodunit details from mastermind identity thieves who have pilfered money from half the members of the Forbes 400, as well as exclusive interviews with a myriad of criminals in the Internet's underground, such as Russian hackers who have extorted money from U.S. banks. The book also issues a scathing indictment of the credit granting industry, from credit card issuers to the secretive credit reporting agencies, who have misunderstood the crime from the start, have been slow to respond, and bear much of the responsibility for the epidemic. Finally, Bob Sullivan, author and identity theft expert, probes the tepid solutions now being cobbled together by the industry and government. Bob Sullivan (Snohomish, WA), senior technology writer for MSNBC.com, is the nation's leading journalist covering identity fraud. He has written more than 100 articles on the subject since 1996, and is a regular contributor to MSNBC, CNBC, NBC Nightly News, the Today show, and various local NBC affiliates. With colleague Mike Brunker, Sullivan received the prestigious 2002 Society of Professional Journalists Public Service Award for ongoing coverage of Internet fraud.

BACE inhibitors and their use in the treatment of Alzheimer's Disease BACE (?-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease covers virtually all aspects of BACE from initial identification, discovery of inhibitors, and challenges in clinical development, while providing a global understanding essential for productive and successful drug discovery. This book details the story of the discovery of BACE and its role in AD and comprehensively discusses: The development of BACE inhibitors as therapeutics for Alzheimer's disease The research that led to the identification of BACE New BACE inhibitors currently being clinically tested ADME (absorption, distribution, metabolism, excretion) and clinical trial design—topics not addressed in current field literature Cutting-edge technology such as high-throughput screening, structure-based drug design, and QSAR in context of BACE inhibitors and Alzheimer's drug discovery Other approaches to BACE inhibition based on interaction with the precursor protein APP By enhancing the reader's understanding of the various aspects of the BACE drug-discovery process, this much-needed reference will serve as a key resource for all scientists involved in Alzheimer's research—and inspire new approaches to treatment of AD.

The reference is a broad-ranging review of Alzheimer's disease and other dementias from both basic and clinical neuroscience perspectives; it provides scientists and medical professionals with an extensive introduction and an up-to-date review of cutting-edge scientific advances. Brings the reader up-to-date with cutting-edge developments in this exciting and fast-paced field Summarizes the most recent developments in the fields of Alzheimer's disease and dementia Brings together articles from a prominent and international group of contributors Encompasses a unique range of topics, combining basic molecular perspectives and cognitive neurosciences